Nivolumab for the treatment of unresectable pleural mesothelioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nivolumab for the treatment of unresectable pleural mesothelioma

Published:2019-12-16 Issue:2 Volume:20 Page:109-114
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Hotta Katsuyuki¹²,Fujimoto Nobukazu³,Kozuki Toshiyuki⁴,Aoe Keisuke⁵,Kiura Katsuyuki²

Affiliation:

1. Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan

2. Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan

3. Department of Medical Oncology and Medicine, Okayama Rosai Hospital, Okayama, Japan

4. Department of Respiratory Medicine, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan

5. Department of Medical Oncology, National Hospital Organization Yamaguchi-Ube Medical Center, Ube, Japan

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1703945

Reference41 articles.

1. Mesothelioma Not Associated With Asbestos Exposure

2. Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic

3. Simian virus 40 and human tumors: It is time to study mechanisms

4. Molecular Pathogenesis of Malignant Mesothelioma and its Relationship to Simian Virus 40

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Potential of Neoantigen-Targeted Immunotherapies in Rare Cancers;Handbook of Cancer and Immunology;2024

2. Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments;Cancers;2022-10-21

3. Repurposing therapeutics for malignant pleural mesothelioma (MPM) – Updates on clinical translations and future outlook;Life Sciences;2022-09

4. Prognostic impact of inflammation in malignant pleural mesothelioma: A large-scale analysis of consecutive patients;Lung Cancer;2022-04

5. Primary malignant pericardial mesothelioma in a patient with a history of thoracic radiotherapy and asbestos exposure: A case report;Annals of Cancer Research and Therapy;2022-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3